Toxic epidermal necrolysis and hemolytic uremic syndrome after allogeneic stem-cell transplantation

Pediatric Transplantation

Volumn 11, Issue 6, 2007, Pages 689-693

  Arvidson, Johan ^a   Kildal, Morten ^a   Linde, Torbjörn ^a   Gedeborg, Rolf ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allogeneic stem cell transplantation; Children; Cyclosporine A; Hemolytic uremic syndrome; Plasmapheresis; Toxic epidermal necrolysis

Indexed keywords

ACICLOVIR; ALIMEMAZINE; ALLOPURINOL; AMPICILLIN; CASPOFUNGIN; CEFTAZIDIME; CODEINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXCHLORPHENIRAMINE; FLUCONAZOLE; FUROSEMIDE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; LACTULOSE; MEROPENEM; MESNA; METHOTREXATE; METHYLPREDNISOLONE; MORPHINE; NIFEDIPINE; ONDANSETRON; PARACETAMOL; PREDNISONE; RANITIDINE; STEROID; UNINDEXED DRUG; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; BURN UNIT; CASE REPORT; CYTOMEGALOVIRUS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENDOTRACHEAL INTUBATION; GRAFT VERSUS HOST REACTION; HEMOFILTRATION; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; INFECTION CONTROL; INTENSIVE CARE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PLASMAPHERESIS; SCHOOL CHILD; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; TRACHEOSTOMY; VENTILATOR; WHOLE BODY RADIATION; WOUND CARE; WOUND HEALING;

CHILD; EPIDERMAL NECROLYSIS, TOXIC; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; STEM CELL TRANSPLANTATION;

EID: 34547425803     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00743.x     Document Type: Article

References (20)

1. Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: Current evidence, practical management and future directions. Br J Dermatol 2005 : 153 : 241 253.
2. Villada G, Roujeau JC, Cordonnier C, et al. Toxic epidermal necrolysis after bone marrow transplantation: Study of nine cases. J Am Acad Dermatol 1990 : 23 : 870 875.
3. Friedman HZ, Arias AM, Catchatourian R, Fretzin DF. Toxic epidermal necrolysis following bone marrow transplantation. Cutis 1984 : 34 : 158 162.
4. McDonald BJ, Singer JW, Bianco JA. Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. Ann Pharmacother 1992 : 26 : 34 35.
5. Stone N, Sheerin S, Burge S. Toxic epidermal necrolysis and graft vs. host disease: A clinical spectrum but a diagnostic dilemma. Clin Exp Dermatol 1999 : 24 : 260 262.
6. Takeda H, Mitsuhashi Y, Kondo S, Kato Y, Tajima K. Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation. J Dermatol 1997 : 24 : 635 641.
7. Roy V, Rizvi MA, Vesely SK, George JN. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: An analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 2001 : 27 : 641 646.
8. Paquet P, Arrese JE, Beguin Y, Pierard GE. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction. Curr Top Pathol 2001 : 94 : 49 63.
9. Herndon DN. Toxic epidermal necrolysis: A systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids. J Am Coll Surg 1995 : 180 : 340 342.
10. Stables GI, Lever RS. Toxic epidermal necrolysis and systemic corticosteroids. Br J Dermatol 1993 : 128 : 357.
11. Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 1986 : 204 : 503 512.
12. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995 : 333 : 1600 1607.
13. Harkness DR, Byrnes JJ, Lian EC, Williams WD, Hensley GT. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 1981 : 246 : 1931 1933.
14. McLeod BC, Wu KK, Knospe WH. Plasmapheresis in thrombotic thrombocytopenic purpura. Arch Int Med 1980 : 140 : 1059 1060.
15. Sarode R, McFarland JG, Flomenberg N, et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1995 : 16 : 271 275.
16. Chown SR, Goulden N, Cornish JM, et al. The role of plasma exchange for TTP/HUS post-bone marrow transplant. Bone Marrow Transplant 1996 : 17 : 898 899.
17. Dua A, Zeigler ZR, Shadduck RK, et al. Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: A case series. J Clin Apher 1996 : 11 : 176 184.
18. Plews DE, Turner ML, Wallace WH. Plasma exchange as successful treatment of thrombotic thrombocytopenic purpura post autologous bone marrow transplant in a child. Bone Marrow Transplant 2000 : 25 : 679 680.
19. Kolker O, Sviri S, Linton DM, et al. Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation. Acta Haematol 2001 : 105 : 156 158.
20. Teruya J, Styler M, Verde S, Topolsky D, Crilley P. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. J Clin Apher 2001 : 16 : 169 174.